Ohshio G - Search Results

1

Clinical implication of anti-p53 antibodies and p53-protein in pancreatic disease.

Ohshio G, Suwa H, Imamura M. Ohshio G, et al. Int J Gastrointest Cancer. 2002;31(1-3):129-35. doi: 10.1385/IJGC:31:1-3:129. Int J Gastrointest Cancer. 2002. PMID: 12622424 Clinical Trial.

2

Immunohistochemical study of metallothionein in pancreatic carcinomas.

Ohshio G, Imamura T, Okada N, Wang ZH, Yamaki K, Kyogoku T, Suwa H, Yamabe H, Imamura M. Ohshio G, et al. J Cancer Res Clin Oncol. 1996;122(6):351-5. doi: 10.1007/BF01220802. J Cancer Res Clin Oncol. 1996. PMID: 8642045

3

Clinical significance of serum p53 antigen in patients with pancreatic carcinomas.

Suwa H, Ohshio G, Okada N, Wang Z, Fukumoto M, Imamura T, Imamura M. Suwa H, et al. Among authors: ohshio g. Gut. 1997 May;40(5):647-53. doi: 10.1136/gut.40.5.647. Gut. 1997. PMID: 9203945 Free PMC article.

4

Cytokeratin 19 fragment in serum and tissues of patients with pancreatic diseases.

Ohshio G, Imamura T, Okada N, Yamaki K, Suwa H, Imamura M, Sakahara H. Ohshio G, et al. Int J Pancreatol. 1997 Jun;21(3):235-41. doi: 10.1007/BF02821609. Int J Pancreatol. 1997. PMID: 9322122 Clinical Trial.

5

An immunohistochemical study of bcl-2 and p53 protein expression in pancreatic carcinomas.

Ohshio G, Suwa H, Imamura T, Yamaki K, Tanaka T, Hashimoto Y, Imamura M. Ohshio G, et al. Scand J Gastroenterol. 1998 May;33(5):535-9. doi: 10.1080/00365529850172124. Scand J Gastroenterol. 1998. PMID: 9648995

6

Elevated serum c-erbB-2 protein levels in patients with pancreatic cancer: correlation to metastasis and shorter survival.

Okada N, Ohshio G, Yamaki K, Imamura T, Imamura M. Okada N, et al. Among authors: ohshio g. Oncology. 1995 Sep-Oct;52(5):392-6. doi: 10.1159/000227495. Oncology. 1995. PMID: 7637957

7

Distribution of Tn antigen recognized by an anti-Tn monoclonal antibody (MLS128) in normal and malignant tissues of the digestive tract.

Ohshio G, Imamura T, Imamura M, Yamabe H, Sakahara H, Nakada H, Yamashina I. Ohshio G, et al. J Cancer Res Clin Oncol. 1995;121(4):247-52. doi: 10.1007/BF01366970. J Cancer Res Clin Oncol. 1995. PMID: 7751324

8

Distribution of the carbohydrate antigens, DU-PAN-2 and CA19-9, in tumors of the lung.

Ohshio G, Yamaki K, Imamura T, Suwa H, Chang CY, Wada H, Sueno Y, Imamura M. Ohshio G, et al. Tumori. 1995 Jan-Feb;81(1):67-73. doi: 10.1177/030089169508100116. Tumori. 1995. PMID: 7754546

9

Expression of sialosyl-Tn antigen (monoclonal antibody MLS102 reactive) in normal tissues and malignant tumors of the digestive tract.

Ohshio G, Yoshioka H, Manabe T, Sakahara H, Yamabe H, Imamura M, Inoue M, Tanaka N, Nakada H, Yamashina I. Ohshio G, et al. J Cancer Res Clin Oncol. 1994;120(6):325-30. doi: 10.1007/BF01247457. J Cancer Res Clin Oncol. 1994. PMID: 8138557

10

Nuclear DNA content as a prognostic predictor in carcinoma of the pancreas.

Yoshimura T, Manabe T, Suwa H, Imamura T, Wang Z, Ohshio G, Yamabe H, Matsumoto M, Ogasahara K, Takasan H. Yoshimura T, et al. Among authors: ohshio g. Int J Pancreatol. 1993 Aug;14(1):29-36. doi: 10.1007/BF02795227. Int J Pancreatol. 1993. PMID: 8409574

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

128 results

Search Page

Filters